Source briefing
Global regulators call for advancing alternatives to animal testing across the medicine lifecycle
EMA has endorsed a joint statement from the International Coalition of Medicines Regulatory Authorities (ICMRA) calling on medicine developers, manufacturers, regulators and…
Read →Source briefing
US: Nebraskans Losing Coverage as Medicaid Changes
Nebraska’s efforts to implement new, federally mandated work requirements for Medicaid underscore fears that millions of people will experience avoidable barriers to healthcare coverage.Federal authorities could have chosen to blunt the impact of the federal legislation’s Medicaid cuts.…
Read →
Source briefing
Taking vital training home
With help from the i-Lab, two students tackle improving education in the DRC, healthcare in rural Mongolia
Read →Source briefing
Egyptian Security Services Arrest Entire Newsroom within 24 Hours
Egyptian security services have arrested six journalists between Monday and Tuesday, all working for local independent investigative journalism platform Matsadaash. According to a statement published by the news platform on Wednesday, the crackdown began with raids on the…
Read →
Source briefing
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 63, Status: Authorised
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 63, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 63, Status: Authorised
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 63, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 4, Status: Authorised
Read →Source briefing
Women are missing from medicines development: EMA’s roadmap for change
By the end of 2026, EMA will develop a regulatory roadmap to help drive decisive change on how women’s health is considered across medicines development and regulation. This…, Women are still missing: from research and data, prevention, diagnosis…
Read →Source briefing
Selective serotonin reuptake inhibitors and immune checkpoint blockade in solid tumors: A target trial emulation with pan-cancer transcriptomic analyses
by Po-Huang Chen, Ming-Shen Dai, Mao-Hsuan Huang, Hsin-Yu Chen, Li-Ting Kao, Tina Yi-Jin Hsieh, Hong-Jie Jhou, Cho-Hao Lee Background Preclinical evidence identifies the serotonin transporter (SERT, encoded by SLC6A4) as an immune checkpoint on CD8+ T cells, with selective…
Read →Source briefing
Medicine shortages and availability issues
Medicine shortages and availability issues
Read →